116 related articles for article (PubMed ID: 2142432)
21. The CD4 cell dependency of SJL/J B-cell lymphomas as a target for cyclophosphamide therapy.
Thrush GR; Placey JL; Valeriote FA; Lerman SP
Cancer Commun; 1989; 1(5):301-10. PubMed ID: 2518399
[TBL] [Abstract][Full Text] [Related]
22. Cognate interactions between helper T cells and B cells. II. Dissection of cognate help by using a class II-restricted, antigen-specific, IL-2-dependent helper T cell clone.
Bartlett WC; Michael A; McCann J; Yuan D; Claassen E; Noelle RJ
J Immunol; 1989 Sep; 143(6):1745-54. PubMed ID: 2476481
[TBL] [Abstract][Full Text] [Related]
23. The targeting of CD4+ T lymphocytes to a B cell lymphoma. A comparison of anti-CD3-anti-idiotype antibody conjugates and antigen-anti-idiotype antibody conjugates.
Gravelle M; Ochi A
J Immunol; 1989 Jun; 142(11):4079-84. PubMed ID: 2523940
[TBL] [Abstract][Full Text] [Related]
24. On the molecular basis of T-helper-cell function. IV. B-lymphocyte-promotor factors: on their mode of action, biochemical nature and possible relationship to molecules involved in specific T-helper-cell activity.
Reininger L; Fueri J; Boned A; Prat M; Landolfo S; Rubin B
Cell Immunol; 1985 Apr; 92(1):85-104. PubMed ID: 2416480
[TBL] [Abstract][Full Text] [Related]
25. A functional idiotypic network of T helper cells and antibodies, limited to the compartment of "naturally" activated lymphocytes in normal mice.
Coutinho A; Marquez C; Araujo PM; Pereira P; Toribio ML; Marcos MA; Martinez C
Eur J Immunol; 1987 Jun; 17(6):821-5. PubMed ID: 2954828
[TBL] [Abstract][Full Text] [Related]
26. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
Ohnishi K; Bonavida B
J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
[TBL] [Abstract][Full Text] [Related]
27. T-independent and T-dependent B lymphoblasts: helper T cells prime for interleukin 2-induced growth and secretion of immunoglobulins that utilize downstream heavy chains.
Forman MS; Puré E
J Exp Med; 1991 Mar; 173(3):687-97. PubMed ID: 1825505
[TBL] [Abstract][Full Text] [Related]
28. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
Wilbur SM; Marelli O; Bonavida B
Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
[TBL] [Abstract][Full Text] [Related]
29. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
30. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
Tsiagbe VK; Asakawa J; Miranda A; Sutherland RM; Paterson Y; Thorbecke GJ
J Immunol; 1993 Jun; 150(12):5519-28. PubMed ID: 8099938
[TBL] [Abstract][Full Text] [Related]
31. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
[TBL] [Abstract][Full Text] [Related]
32. Idiotype-specific helper cells (BH) express immunoglobulin markers and employ T cell function-associated molecules.
Sherr DH; Ju ST
J Immunol; 1986 Dec; 137(11):3406-13. PubMed ID: 2946760
[TBL] [Abstract][Full Text] [Related]
33. Syngeneic B lymphoma cells provide a unique stimulus to natural killer (NK) cells in genetically low-NK SJL/J mice.
Lin TZ; Ponzio NM
J Leukoc Biol; 1991 Jan; 49(1):48-57. PubMed ID: 1984485
[TBL] [Abstract][Full Text] [Related]
34. A noncognate interaction with anti-receptor antibody-activated helper T cells induces small resting murine B cells to proliferate and to secrete antibody.
Owens T
Eur J Immunol; 1988 Mar; 18(3):395-401. PubMed ID: 2965646
[TBL] [Abstract][Full Text] [Related]
35. Antigen-specific, MHC-restricted B cell activation by cell-free Th2 cell products. Synergy between antigen-specific helper factors and IL-4.
Guy R; Hodes RJ
J Immunol; 1989 Sep; 143(5):1433-40. PubMed ID: 2474597
[TBL] [Abstract][Full Text] [Related]
36. Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.
Bridges SH; Kruisbeek AM; Longo DL
J Immunol; 1987 Dec; 139(12):4242-9. PubMed ID: 3500981
[TBL] [Abstract][Full Text] [Related]
37. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
Bonavida B; Roman JM; Hutchinson IV
Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
[TBL] [Abstract][Full Text] [Related]
38. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
[TBL] [Abstract][Full Text] [Related]
39. Comparative growth of SJL/J lymphomas in irradiated and normal SJL/J mice: cell cycle distribution and tumor cell quantification.
Rosloniec EF; Gottlieb C; Butch AW; Lerman SP
J Natl Cancer Inst; 1985 Nov; 75(5):877-83. PubMed ID: 3903308
[TBL] [Abstract][Full Text] [Related]
40. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.
He XY; Chen J; Verma N; Plain K; Tran G; Hall BM
Transplantation; 1998 May; 65(9):1145-52. PubMed ID: 9603159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
